Simrone Pharmaceutical Industries Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1991.

1991 Mumbai, Maharashtra, India Struck Off

Last Updated: July 23, 2025

About Simrone Pharmaceutical Industries Limited

Simrone Pharmaceutical Industries Limited, a struck off public limited company, was established on 18 July 1991 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24139MH1991PLC062545. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.50 Cr and a paid-up capital of ₹0.90 M.

Formerly known as Simrone Pharmaceutical Industries Private Limited. It upholds a compliant status. Its leadership includes Susan Teresa Noronha (Director), Simrone Noronha (Director), Sinhue Bosco Noronha (Managing Director). Past directors included Umakant Ramchandra Walawalkar, Kalyanmal Sawantraj Mehta, Dilip Kalyanmal Mehta. It holds no open charges and ₹4.90 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 10, Sai Sundaram, Sai Baba Complex Goregaon (E), Mumbai, Maharashtra, 400063.

Company Details

CIN/LLPIN
U24139MH1991PLC062545
Registration Number
062545
Incorporation Date
18 July 1991
Authorized Capital
₹3.50 Cr
Paid-Up Capital
₹0.90 M
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Struck Off

Key Metrics

Authorised Capital ₹ 3.50 Cr as on 23-07-2025
Paid Up Capital ₹ 0.90 M as on 23-07-2025
Company Age 34 Year, 7 Months
Last Filing with ROC 31 Mar 2023
Satisfied Charges ₹ 4.90 Cr as on 23-07-2025
Revenue Growth **** % (FY 2022)
Profit Growth **** 6.06% (FY 2022)
Ebitda **** 6.06% (FY 2022)
Net Worth -10.65% (FY 2022)
Total Assets -4.95% (FY 2022)

Comprehensive Company Insights

Explore comprehensive insights into Simrone Pharmaceutical Industries Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Simrone Pharmaceutical Industries Limited?

Current Directors

Name	Designation	Appointment Date	Status
Susan Teresa Noronha	Director	20 Aug 2012	Current
Simrone Noronha	Director	20 Aug 2012	Current
Sinhue Bosco Noronha	Managing Director	18 Jul 1991	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Whole-Time Director	30 Sep 2014	Past
Pramod Abcsdd	Director	23 Aug 2012	Past
Pramod Abcsdd	Director	23 Aug 2012	Past
Pramod Abcsdd	Whole-Time Director	23 Aug 2012	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Simrone Pharmaceutical Industries.

Simrone Pharmaceutical Industries Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 6.06% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.65%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

-4.95%

*******

Profit or Loss

*******

6.06%

*******

Net Worth

*******

-10.65%

*******

EBITDA

*******

6.06%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Simrone Pharmaceutical Industries?

In 2023, Simrone Pharmaceutical Industries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹49,000,000.00

Charges Breakdown by Lending Institutions

Dena Bank : 4.70 Cr
Maharashtra Apex Corporation Ltd. : 0.20 Cr

Latest Charge Details

Date	Lender	Amount	Status
19 Jun 1997	Dena Bank	₹7.50 M	Satisfied
04 Jun 1997	Dena Bank	₹3.70 Cr	Satisfied
15 Apr 1994	Maharashtra Apex Corporation Ltd.	₹2.00 M	Satisfied
05 Apr 1992	Dena Bank	₹2.50 M	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Simrone Pharmaceutical Industries?

Unlock and access historical data on people associated with Simrone Pharmaceutical Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Simrone Pharmaceutical Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Simrone Pharmaceutical Industries's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Simrone Pharmaceutical Industries

Recent Activity within the Organization

Annual General Meeting

The activity Simrone Pharmaceutical Industries Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
30 Sep 2023
Balance Sheet

Progress on Simrone Pharmaceutical Industries Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was documented.
31 Mar 2023
Director Appointment

The activity Susan Teresa Noronha was appointed as a Director was appointed as a Director on 20 Aug 2012 & has been associated with this company since 13 years 5 months . was completed.
20 Aug 2012
Director Appointment

The activity Simrone Noronha was appointed as a Director was appointed as a Director on 20 Aug 2012 & has been associated with this company since 13 years 5 months . was completed.
20 Aug 2012
Charges

Progress on A charge registered on 19 Jun 1997 via Charge ID 90361608 with Dena Bank was fully satisfied on 02 Apr 2008. was documented.
02 Apr 2008
Charges

A charge registered on 04 Jun 1997 via Charge ID 90361607 with Dena Bank was fully satisfied on 02 Apr 2008. was recorded as a recent event.
02 Apr 2008

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Simrone Pharmaceutical Industries Limited?

The CIN of Simrone Pharmaceutical Industries Limited is U24139MH1991PLC062545.

Where is Simrone Pharmaceutical Industries Limited headquartered?

Simrone Pharmaceutical Industries Limited is headquartered at 10, Sai Sundaram, Sai Baba Complex Goregaon (E), Mumbai, Maharashtra, 400063.

When was Simrone Pharmaceutical Industries Limited incorporated?

Simrone Pharmaceutical Industries Limited was incorporated on 18 July 1991.

Who are the current directors of Simrone Pharmaceutical Industries Limited?

The current directors of Simrone Pharmaceutical Industries Limited are

What is the primary industry of Simrone Pharmaceutical Industries Limited?

The primary industry of Simrone Pharmaceutical Industries Limited is Pharma.

Is Simrone Pharmaceutical Industries Limited a listed company?

Simrone Pharmaceutical Industries Limited is unlisted.

What is the capital structure of Simrone Pharmaceutical Industries Limited?

The authorized capital of Simrone Pharmaceutical Industries Limited is ₹3.50 Cr, and the paid-up capital is ₹0.90 M.

What is the compliance status of Simrone Pharmaceutical Industries Limited?

The compliance status of Simrone Pharmaceutical Industries Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available